Clay Thorp Insider Trading $GTHX G1 Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Clay Thorp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Clay Thorp. Clay Thorp is Director in PhaseBio Pharmaceuticals Inc ($PHAS) and Director in Clearside Biomedical, Inc. ($CLSD) and 10% Owner in G1 Therapeutics, Inc. ($GTHX).
Clay Thorp in G1 Therapeutics, Inc.
Trading Symbol: GTHXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Clay Thorp: 10% Owner
Holdings: 3,279,421 shares
Latest Transaction: Jun 01 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Clay Thorp in G1 Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CLSD, GTHX, PHAS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 01 2018 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Sell | S | 48.00 | 41,710 | 2,002,080 | 3,237,711 | 3.3 M to 3.2 M (-1.27 %) |
Jun 01 2018 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Sell | S | 48.00 | 758,290 | 36,397,920 | 3,279,421 | 4 M to 3.3 M (-18.78 %) |
May 23 2018 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Sell | S | 50.50 | 26 | 1,313 | 4,037,711 | 4 M to 4 M (0.00 %) |
May 23 2018 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Sell | S | 50.50 | 474 | 23,937 | 4,037,737 | 4 M to 4 M (-0.01 %) |
May 23 2018 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Sell | S | 50.69 | 308 | 15,611 | 4,038,211 | 4 M to 4 M (-0.01 %) |
May 23 2018 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Sell | S | 50.86 | 5,592 | 284,405 | 4,038,519 | 4 M to 4 M (-0.14 %) |
May 23 2018 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Sell | S | 52.13 | 26 | 1,355 | 4,044,111 | 4 M to 4 M (0.00 %) |
May 23 2018 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Sell | S | 52.13 | 474 | 24,710 | 4,044,137 | 4 M to 4 M (-0.01 %) |
May 23 2018 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Sell | S | 51.06 | 1,595 | 81,439 | 4,044,611 | 4 M to 4 M (-0.04 %) |
May 23 2018 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Sell | S | 51.16 | 29,005 | 1,483,907 | 4,046,206 | 4.1 M to 4 M (-0.71 %) |
Dec 04 2017 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Buy | J | 0.00 | 995 | 0 | 4,075,211 | 4.1 M to 4.1 M (+0.02 %) |
Dec 04 2017 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Sell | J | 0.00 | 99,513 | 0 | 4,074,216 | 4.2 M to 4.1 M (-2.38 %) |
May 24 2017 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Option Exercise | C | 0.00 | 1,009,693 | 0 | 0 | |
May 24 2017 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Option Exercise | C | 0.00 | 2,584,959 | 0 | 0 | |
May 24 2017 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Option Exercise | C | 0.00 | 6,568,527 | 0 | 0 | |
May 24 2017 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Option Exercise | C | 0.00 | 1,318,681 | 0 | 0 | |
May 24 2017 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,861,797 | 3.7 M to 3.9 M (+3.58 %) |
May 24 2017 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Buy | C | 0.00 | 99,513 | 0 | 99,513 | 0 to 99.5 K |
May 24 2017 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Buy | C | 0.00 | 212,419 | 0 | 212,419 | 0 to 212.4 K |
May 24 2017 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Buy | C | 0.00 | 3,728,464 | 0 | 3,728,464 | 0 to 3.7 M |
Page: 1